TY  - JOUR
AU  - Arriola, Edurne
AU  - Gonzalez-Cao, Maria
AU  - Domine, Manuel
AU  - De-Castro, Javier
AU  - Cobo, Manuel
AU  - Bernabe, Reyes
AU  - Navarro, Alejandro
AU  - Sullivan, Ivana
AU  - Trigo, Jose Manuel
AU  - Mosquera, Joaquin
AU  - Crama, Leonardo
AU  - Isla, Dolores
PY  - 2022
DO  - 10.1007/s40487-021-00182-0
UR  - http://hdl.handle.net/10668/21742
T2  - Oncology and therapy
AB  - The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment improves survival in extensive-stage small-cell lung cancer (ES-SCLC). The aim of this meta-analysis was to determine the relative efficacy...
LA  - en
PB  - Springer
KW  - Anti-PD-1/PD-L1 antibodies
KW  - Chemotherapy
KW  - Immunotherapy
KW  - Meta-analysis
KW  - Small cell lung carcinoma
KW  - Lung Neoplasms
KW  - Immune Checkpoint Inhibitors
KW  - Platinum
KW  - Progression-Free Survival
KW  - Confidence Intervals
KW  - Ligands
TI  - Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
TY  - research article
VL  - 10
ER  -